2022
DOI: 10.1016/j.ijbiomac.2022.06.021
|View full text |Cite
|
Sign up to set email alerts
|

Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 44 publications
0
4
0
Order By: Relevance
“…Apart from heterologous RNAs, a wide range of other non-viral cargo has also been packaged by self-assembled viral capsid proteins of CCMV; for example, anionic polymers [ 25 ], mineralized salts [ 26 ], gold nanoparticles [ 27 ], and fluorescent proteins [ 28 ]. In addition, CCMV VLPs were recently studied as potential candidates for in situ cancer vaccines [ 29 ] and scaffolds to display SARS-CoV-2 antigens [ 30 ].…”
Section: Introductionmentioning
confidence: 99%
“…Apart from heterologous RNAs, a wide range of other non-viral cargo has also been packaged by self-assembled viral capsid proteins of CCMV; for example, anionic polymers [ 25 ], mineralized salts [ 26 ], gold nanoparticles [ 27 ], and fluorescent proteins [ 28 ]. In addition, CCMV VLPs were recently studied as potential candidates for in situ cancer vaccines [ 29 ] and scaffolds to display SARS-CoV-2 antigens [ 30 ].…”
Section: Introductionmentioning
confidence: 99%
“…It can take several weeks before the antigen is available for immunization. Many antigens are produced in intracellular compartments, which require isolation by cellular lysis, purification by chromatography, and often solubilization or refolding in order to obtain the desired protein conformation [ 6–9 ]. Reduction of process steps for antigen production will reduce overall the costs of manufacturing mAbs [ 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…Apart from heterologous RNAs, a wide range of other non-viral cargo has also been packaged by self-assembled viral capsid proteins of CCMV, for example, anionic polymers [24], mineralized salts [25], gold nanoparticles [26], and fluorescent proteins [27]. In addition, CCMV VLPs were recently studied as potential candidates for in situ cancer vaccines [28] and scaffolds to display SARS-CoV-2 antigens [29].…”
Section: Introductionmentioning
confidence: 99%